Investigating the phenotypic alterations associated with hypermucoviscous hypervirulent Klebsiella pneumoniae during

Ramya Juliet1, Ramesh Nachimuthu2

  • 1Antibiotic Resistance and Phage Therapy Laboratory, Centre for Advanced Research in Bacteriophage and Infectious Diseases, School of Bio Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, 632014, Tamil Nadu, India.

BMC Microbiology
|August 22, 2025
PubMed

Insights

Phage therapy faces challenges from bacterial resistance. This study shows Klebsiella pneumoniae can develop phage resistance, altering its traits and antibiotic susceptibility, impacting therapeutic options.

Area of Science:

  • Microbiology
  • Bacteriology
  • Virology

Background:

  • Phage therapy is a promising alternative in the post-antibiotic era.
  • Hypervirulent and hypermucoviscous Klebsiella pneumoniae presents significant therapeutic challenges.
  • Bacterial resistance to phages is a critical concern for therapeutic efficacy.

Purpose of the Study:

  • To investigate phage resistance in a hypermucoviscous, hypervirulent Klebsiella pneumoniae clinical strain (Kleb_53).
  • To characterize the phenotypic and genotypic changes in phage-resistant Kleb_53 variants.
  • To assess the impact of phage resistance on antibiotic susceptibility and biofilm formation.

Main Methods:

  • Isolation and characterization of a Klebsiella phage (Phage Disc) effective against Kleb_53.
  • Determination of phage stability across temperature and pH ranges.
  • Screening and examination of phage-resistant Kleb_53 variants for phenotypic variations, antibiotic susceptibility, and biofilm formation.

Main Results:

  • Phage Disc demonstrated stability between -20°C and 60°C and pH 3-11.
  • Phage-resistant Kleb_53 variants exhibited reduced mucoviscosity and altered colony morphotypes.
  • Reversal of resistance to meropenem and cephalosporins was observed in some variants, with varied biofilm formation.

Conclusions:

  • Phage-host interactions drive phenotypic changes and the emergence of phage-resistant variants.
  • Phage resistance in Klebsiella pneumoniae can lead to altered antibiotic susceptibility and biofilm capacity.
  • Further research is needed to overcome phage resistance for effective phage therapy.

Related Concept Videos

Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
230
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
63.2K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.9K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
243
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K